Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Account Payables (2022 - 2025)

Historic Change in Account Payables for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$795000.0.

  • Gossamer Bio's Change in Account Payables fell 16949.15% to -$795000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.5 million, marking a year-over-year decrease of 84704.64%. This contributed to the annual value of -$1.7 million for FY2024, which is 14150.38% down from last year.
  • Gossamer Bio's Change in Account Payables amounted to -$795000.0 in Q3 2025, which was down 16949.15% from -$5.8 million recorded in Q2 2025.
  • Gossamer Bio's 5-year Change in Account Payables high stood at $4.3 million for Q4 2023, and its period low was -$5.8 million during Q2 2025.
  • Its 4-year average for Change in Account Payables is -$469866.7, with a median of -$795000.0 in 2025.
  • Its Change in Account Payables has fluctuated over the past 5 years, first skyrocketed by 139543.86% in 2023, then tumbled by 33908.42% in 2024.
  • Quarter analysis of 4 years shows Gossamer Bio's Change in Account Payables stood at $285000.0 in 2022, then soared by 1395.44% to $4.3 million in 2023, then dropped by 27.73% to $3.1 million in 2024, then tumbled by 125.81% to -$795000.0 in 2025.
  • Its last three reported values are -$795000.0 in Q3 2025, -$5.8 million for Q2 2025, and -$937000.0 during Q1 2025.